IRIDEX Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from IRIDEX Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-60.9×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 76% of Healthcare companies in United States.
Cash Locked Ratio
$22For every $100 of sales, $22 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $29 tied up three years earlier.
Less money tied up than 54% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 8%
Sales fell 8% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-8% / -31%In 3 years sales changed by -8% while total assets changed by -31%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-3.0×Operating cash was negative last year, while some debt falls due within a year.
Higher than 62% of Healthcare companies in United States.
Cash Cushion Ratio
+11%Cash, after subtracting all debt, equals 11% of its market value (net cash).
Higher than 52% of Healthcare companies in United States.
Tangible Assets Ratio
93%Of every $100 the company owns, $93 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 67% of Healthcare companies in United States.
Tangible Net Worth Ratio
60%Of every $100 of net worth, $60 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 52% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
IRIDEX Corporation made a loss over the last year. IRIDEX Corporation owes $0.87 for every $1 it owns. IRIDEX Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossIRIDEX Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.68The share price is 3.68 times IRIDEX Corporation's book value per share, higher than 62% of Healthcare companies in United States.
Market cap
$13 MThe total market value of all of IRIDEX Corporation's shares at today's price (share price × number of shares), smaller than 85% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$4 MWhat IRIDEX Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.21Net worth divided by the number of shares. The share price of $0.76 is 3.7 times this, which is the P/B above.
Return on equity (ROE)
-73.2%IRIDEX Corporation lost 73.2% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
Owes vs Owns
0.87×IRIDEX Corporation owes $0.87 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.
Dividend yield
NoneIRIDEX Corporation does not currently pay a dividend.
Revenue growth
+8%Revenue rose 8% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Profit growth
LossIRIDEX Corporation made a loss in each of the last two years.
Profit margin
-8.4%IRIDEX Corporation lost $8 for every $100 of revenue.
Cash vs debt
Net cashIRIDEX Corporation held $1 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For IRIDEX Corporation: $13 M ÷ $4 M (30 Jun 2026) = 3.7.
What is IRIDEX Corporation's return on equity?
IRIDEX Corporation lost 73.2% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
How much does IRIDEX Corporation owe compared with what it owns?
IRIDEX Corporation owes $0.87 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.
Does IRIDEX Corporation pay a dividend?
No. IRIDEX Corporation does not currently pay a dividend.
Is IRIDEX Corporation's revenue growing?
Revenue rose 8% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.